Given this possible protective role against tumorigenesis and cancer progression, loss of SLC38A3 expression might represent a pro-tumorigenic mechanism, in addition to reflecting the dedifferentiation process that inevitably occurs during HCC tumorigenesis. Here, SLC38A3 is linked to hepatocellular carcinoma.